This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Barbara Drobits-Handl: Innovator in Anticancer Therapies
Introduction
Barbara Drobits-Handl is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of cancer research, particularly through her innovative approaches to anticancer therapies. Her work focuses on the development of novel treatment combinations that enhance the efficacy of existing therapies.
Latest Patents
Barbara holds a patent for her invention titled "LRP5 and PD-1 antagonist anticancer combination therapy." This invention describes anti-cancer therapies that utilize an LRP5 antagonist in combination with an anti-PD1 antibody. The combination aims to improve treatment outcomes for patients battling cancer.
Career Highlights
Barbara is affiliated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. Her role at the company allows her to collaborate with other experts in the field and contribute to groundbreaking research and development in cancer therapies.
Collaborations
Throughout her career, Barbara has worked alongside notable colleagues such as Vittoria Zinzalla and Markus Johann Bauer. These collaborations have further enriched her research and have led to advancements in the understanding and treatment of cancer.
Conclusion
Barbara Drobits-Handl's innovative work in anticancer therapies exemplifies the impact of dedicated research in the medical field. Her contributions continue to pave the way for new treatment options that can significantly benefit patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile